Arecor Therapeutics PLC (AREC) — Financial Flexibility Index
Arecor Therapeutics PLC (AREC) has a Financial Flexibility Index of -0.44x as of June 2025. Free cash flow of GBX-1.04 Million (operating CF GBX-1.14 Million minus capex GBX98.00K) represents 0% of total liabilities (GBX2.39 Million). Also explore AREC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arecor Therapeutics PLC Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Arecor Therapeutics PLC across 8 annual periods. Check Arecor Therapeutics PLC strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Arecor Therapeutics PLC (2018–2024)
Year-by-year free cash flow to debt coverage for Arecor Therapeutics PLC. For the full company profile including market capitalisation, see AREC stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.71x | GBX-9.13 Million | GBX-9.15 Million | GBX3.37 Million | ▼ -178.4% |
| 2023 | -0.97x | GBX-5.69 Million | GBX-5.84 Million | GBX5.85 Million | ▲ +59.8% |
| 2022 | -2.42x | GBX-10.44 Million | GBX-10.78 Million | GBX4.31 Million | ▼ -6.7% |
| 2021 | -2.27x | GBX-5.38 Million | GBX-5.45 Million | GBX2.37 Million | ▼ -341.3% |
| 2020 | -0.51x | GBX-1.80 Million | GBX-1.86 Million | GBX3.51 Million | ▼ -32.3% |
| 2019 | -0.39x | GBX-426.50K | GBX-458.80K | GBX1.10 Million | ▲ +80.3% |
| 2019 | -1.97x | GBX-2.43 Million | GBX-2.50 Million | GBX1.23 Million | ▼ -473.2% |
| 2018 | -0.34x | GBX-479.65K | GBX-492.57K | GBX1.40 Million | — |